ROZ.XC Roche Holding AG
Healthcare · Drug Manufacturers - General
371.40
+1.31%
About the company
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
52-week range
Dividend deep dive
Roche Holding AG operates in the Drug Manufacturers - General industry within the Healthcare sector. The company's current dividend yield is 2.89%, which is below its 5-year average yield of 3.42%. The current yield is also below the 5-year high of 3.53% and low of 3.31%, with Yield Theory indicating the stock is overvalued. The company holds a rating score of 5.0.
Dividend history
Roche Holding AG currently has a dividend increase streak of 1 year. The company pays dividends annually, typically in March. No 3-year or 5-year Dividend CAGR figures are available in the provided data. The historical annual dividends per share are: CHF 7.35 in 2013, CHF 7.8 in 2014, CHF 8.0 in 2015, CHF 8.1 in 2016, CHF 8.2 in 2017, CHF 8.3 in 2018, and CHF 8.7 in 2019. Forward-looking dividends are CHF 9.6 for 2024 and CHF 9.7 for 2025.
Dividend safety
The dividend payout ratio for Roche Holding AG is 61.14% based on its EPS of CHF 16.03 and dividend of CHF 9.8. This indicates a moderate portion of earnings is distributed as dividends. As a non-REIT, FFO payout ratio is not applicable.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Appears in these lists
ROZ.XC qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track ROZ.XC and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →